Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

Torsten Dahlén, Leif Stenke, Ulla Olsson‐Strömberg et al.|American Journal of Hematology|2022

Cited by 15